Pricing
Login
Home
Charts
Search
Watchlist
Products

Syncom Formulations (India) Ltd

SYNCOMF
₹21.90-0.86%20 Nov 2026
Reports
Pharma Others

Syncom Formulations (India) Ltd

SYNCOMF
₹21.90
-0.86%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,059Cr
Close
Close Price
₹21.90
Industry
Industry
Pharma Others
PE
Price To Earnings
21.68
PS
Price To Sales
3.97
Revenue
Revenue
₹518Cr
Rev Gr TTM
Revenue Growth TTM
0.62%
PAT Gr TTM
PAT Growth TTM
51.62%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
657587102128149117122115135126142
Growth YoY
Revenue Growth YoY%
13.522.345.860.395.899.734.019.0-9.7-9.17.416.8
Expenses
ExpensesCr
586577901131311011039411399110
Operating Profit
Operating ProfitCr
7910121518161821222632
OPM
OPM%
11.312.612.011.911.611.913.515.118.416.320.922.5
Other Income
Other IncomeCr
5314476561586
Interest Expense
Interest ExpenseCr
110000000000
Depreciation
DepreciationCr
111111111222
PBT
PBTCr
91010151723202225343236
Tax
TaxCr
232446556979
PAT
PATCr
778111318161719252527
Growth YoY
PAT Growth YoY%
69.1-12.673.470.785.7139.1106.449.445.542.357.860.5
NPM
NPM%
10.89.98.710.910.211.913.513.616.418.619.818.8
EPS
EPS₹
0.10.10.10.20.10.20.20.20.20.30.30.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
657587102128149117122115135126142
Growth YoY
Revenue Growth YoY%
13.522.345.860.395.899.734.019.0-9.7-9.17.416.8
Expenses
ExpensesCr
586577901131311011039411399110
Operating Profit
Operating ProfitCr
7910121518161821222632
OPM
OPM%
11.312.612.011.911.611.913.515.118.416.320.922.5
Other Income
Other IncomeCr
5314476561586
Interest Expense
Interest ExpenseCr
110000000000
Depreciation
DepreciationCr
111111111222
PBT
PBTCr
91010151723202225343236
Tax
TaxCr
232446556979
PAT
PATCr
778111318161719252527
Growth YoY
PAT Growth YoY%
69.1-12.673.470.785.7139.1106.449.445.542.357.860.5
NPM
NPM%
10.89.98.710.910.211.913.513.616.418.619.818.8
EPS
EPS₹
0.10.10.10.20.10.20.20.20.20.30.30.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
118115151173184185220224263465489518
Growth
Revenue Growth%
-3.031.614.66.10.52.117.476.55.20.6
Expenses
ExpensesCr
111104135155167168200205234411412417
Operating Profit
Operating ProfitCr
811161817172020305477101
OPM
OPM%
6.59.310.710.59.08.99.18.811.311.615.819.6
Other Income
Other IncomeCr
111233121514173134
Interest Expense
Interest ExpenseCr
000000234111
Depreciation
DepreciationCr
333333455577
PBT
PBTCr
581416161626273466101127
Tax
TaxCr
235665679162531
PAT
PATCr
469101011202025497696
Growth
PAT Growth%
61.164.74.76.11.71.426.195.354.651.6
NPM
NPM%
3.04.96.25.65.65.79.08.99.610.615.618.4
EPS
EPS₹
0.00.00.10.10.10.10.30.20.30.50.81.0
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
118115151173184185220224263465489518
Growth
Revenue Growth%
-3.031.614.66.10.52.117.476.55.20.6
Expenses
ExpensesCr
111104135155167168200205234411412417
Operating Profit
Operating ProfitCr
811161817172020305477101
OPM
OPM%
6.59.310.710.59.08.99.18.811.311.615.819.6
Other Income
Other IncomeCr
111233121514173134
Interest Expense
Interest ExpenseCr
000000234111
Depreciation
DepreciationCr
333333455577
PBT
PBTCr
581416161626273466101127
Tax
TaxCr
235665679162531
PAT
PATCr
469101011202025497696
Growth
PAT Growth%
61.164.74.76.11.71.426.195.354.651.6
NPM
NPM%
3.04.96.25.65.65.79.08.99.610.615.618.4
EPS
EPS₹
0.00.00.10.10.10.10.30.20.30.50.81.0
Sales CAGR
1 Year5%
3 Years30%
5 Years21%
TTM1%
EBITDA CAGR
1 Year43%
3 Years58%
5 Years36%
TTM52%
PAT CAGR
1 Year55%
3 Years56%
5 Years49%
TTM52%
Avg. ROCE
1 Year25%
3 Years18%
5 Years15%
TTM26%
CFO / EBITDA
1 Year75%
3 Years47%
5 Years51%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
227878787886094949494
Reserves
ReservesCr
6517223139131162194248321376
Current Liabilities
Current LiabilitiesCr
2738326055781131075910487
Non Current Liabilities
Non Current LiabilitiesCr
876688910121516
Total Liabilities
Total LiabilitiesCr
123140138175180308378405413534573
Current Assets
Current AssetsCr
6075798683140182275270330357
Non Current Assets
Non Current AssetsCr
6366598997168196130143203216
Total Assets
Total AssetsCr
123140138175180308378405413534573
Financial YearMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
227878787886094949494
Reserves
ReservesCr
6517223139131162194248321376
Current Liabilities
Current LiabilitiesCr
2738326055781131075910487
Non Current Liabilities
Non Current LiabilitiesCr
876688910121516
Total Liabilities
Total LiabilitiesCr
123140138175180308378405413534573
Current Assets
Current AssetsCr
6075798683140182275270330357
Non Current Assets
Non Current AssetsCr
6366598997168196130143203216
Total Assets
Total AssetsCr
123140138175180308378405413534573

Cash Flow

Consolidated
Standalone
Financial YearMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
67024141611-62358
Investing Cash Flow
Investing Cash FlowCr
0-41-23-18-27-4583-18-51
Financing Cash Flow
Financing Cash FlowCr
-6-11-25835-15-68-3
Net Cash Flow
Net Cash FlowCr
-122-11-2163-634
Free Cash Flow
Free Cash FlowCr
67024145-10-141346
CFO To PAT
CFO To PAT%
102.272.21.9233.4131.482.552.5-23.547.476.0
CFO To EBITDA
CFO To EBITDA%
54.341.51.0145.683.981.553.6-20.143.375.0
Financial YearMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
67024141611-62358
Investing Cash Flow
Investing Cash FlowCr
0-41-23-18-27-4583-18-51
Financing Cash Flow
Financing Cash FlowCr
-6-11-25835-15-68-3
Net Cash Flow
Net Cash FlowCr
-122-11-2163-634
Free Cash Flow
Free Cash FlowCr
67024145-10-141346
CFO To PAT
CFO To PAT%
102.272.21.9233.4131.482.552.5-23.547.476.0
CFO To EBITDA
CFO To EBITDA%
54.341.51.0145.683.981.553.6-20.143.375.0

Ratios

Consolidated
Standalone
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1181694533351741549175551,0511,5469682,059
Price To Earnings
Price To Earnings
33.531.148.335.817.115.246.228.141.431.012.721.7
Price To Sales
Price To Sales
1.01.53.01.90.90.84.22.54.03.32.04.0
Price To Book
Price To Book
1.41.94.83.41.61.34.22.23.64.52.34.4
EV To EBITDA
EV To EBITDA
15.827.818.410.59.748.632.035.628.612.420.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
30.530.730.926.128.633.133.237.432.239.939.9
OPM
OPM%
6.59.310.710.59.08.99.18.811.311.615.819.6
NPM
NPM%
3.04.96.25.65.65.79.08.99.610.615.618.4
ROCE
ROCE%
9.914.514.914.212.410.212.110.719.124.626.4
ROE
ROE%
6.59.89.79.59.09.112.48.814.418.420.3
ROA
ROA%
4.66.77.15.95.86.45.36.312.014.316.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1181694533351741549175551,0511,5469682,059
Price To Earnings
Price To Earnings
33.531.148.335.817.115.246.228.141.431.012.721.7
Price To Sales
Price To Sales
1.01.53.01.90.90.84.22.54.03.32.04.0
Price To Book
Price To Book
1.41.94.83.41.61.34.22.23.64.52.34.4
EV To EBITDA
EV To EBITDA
15.827.818.410.59.748.632.035.628.612.420.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
30.530.730.926.128.633.133.237.432.239.939.9
OPM
OPM%
6.59.310.710.59.08.99.18.811.311.615.819.6
NPM
NPM%
3.04.96.25.65.65.79.08.99.610.615.618.4
ROCE
ROCE%
9.914.514.914.212.410.212.110.719.124.626.4
ROE
ROE%
6.59.89.79.59.09.112.48.814.418.420.3
ROA
ROA%
4.66.77.15.95.86.45.36.312.014.316.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr6,1713,7243,3022,0592,0581,569963
Close PriceClose₹190.1684.16468.9521.90335.951,110.15817.60
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE3.7782.519.7421.68111.615.6719.57
Price To SalesPS3.1932.911.393.972.851.710.90
RevenueRevenueCr1,9321132,3695187219181,068
Revenue Growth TTMRev Gr TTM%3,141.0%222.2%6.4%0.6%19.4%11.3%42.7%
PAT Growth TTMPAT Gr TTM%712.6%270.5%283.1%51.6%323.7%317.3%16.8%
Market CapitalizationMkt CapCr6,1713,7243,3022,0592,0581,569963
Close PriceClose₹190.1684.16468.9521.90335.951,110.15817.60
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE3.7782.519.7421.68111.615.6719.57
Price To SalesPS3.1932.911.393.972.851.710.90
RevenueRevenueCr1,9321132,3695187219181,068
Revenue Growth TTMRev Gr TTM%3,141.0%222.2%6.4%0.6%19.4%11.3%42.7%
PAT Growth TTMPAT Gr TTM%712.6%270.5%283.1%51.6%323.7%317.3%16.8%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Load More
Interviews